Skip to main content
TipRanks
Go Ultimate75% OFF

RedHill Biopharma (2RH) Q4 2020 Earnings Report

5 Followers

DE:2RH Q4 2020 EPS Results

Actual EPS
-EUR 585.77
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 297.39

DE:2RH Q4 2020 Revenue Results

Actual Revenue
EUR 19.50M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+1256.49%

Earnings Announcement Details

Quarter
Q4 2020
Date
03/18/2021
Time
Before Open
Conference Call
Thursday, March 18, 2021
DE:2RH Upcoming Earnings

RedHill Biopharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

Q4 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:2RH Earnings History

DE:2RH earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 18, 20272026 (Q4)―-―――
Sep 30, 20262026 (Q2)―-0.91-2.0956.56% (+1.18)
Apr 27, 20262025 (Q4)―-――
Sep 05, 20252025 (Q2)―-2.090―
May 13, 20252025 (Q1)―-――
Apr 10, 20252024 (Q4)―-――
Aug 29, 20242024 (Q2)―0.000.9-100.00% (-0.90)
May 07, 20242024 (Q1)―-――
Apr 08, 20242023 (Q4)―--0.05―
Nov 15, 20232023 (Q3)―0.04-2.16101.67% (+2.20)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed